Regulatory TYKERB® Tablets PMS

Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)]

NCT03292250 ·Status: COMPLETED ·Phase: PHASE2

TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.

NCT01711658 ·Status: COMPLETED ·Phase: PHASE2

Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer

NCT05286060 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck

NCT01075841 ·Status: WITHDRAWN

Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy

NCT02972216 ·Status: COMPLETED

Chemotherapy Plus Radiation Therapy in Treating Patients With Primary Stage IVB Cervical Cancer

NCT03175848 ·Status: UNKNOWN ·Phase: NA

A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)

NCT06459180 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Head and Neck Cancer

NCT01645748 ·Status: COMPLETED ·Phase: PHASE2

Cetuximab + Tislelizumab + Chemotherapy in the Treatment of Unresectable LA HNSCC

NCT06978829 ·Status: RECRUITING ·Phase: PHASE2

Induction Chemotherapy Followed by Chemoradiotherapy for Head and Neck Cancer

NCT01716195 ·Status: COMPLETED ·Phase: PHASE2

A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer

NCT04623333 ·Status: UNKNOWN ·Phase: PHASE2

Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)

NCT00295789 ·Status: COMPLETED ·Phase: PHASE3

Biomarker-Driven Radiation Therapy Dose Reduction After Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer

NCT05387915 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer

NCT00899054 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma

NCT05039892 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive

NCT03808857 ·Status: UNKNOWN ·Phase: PHASE2

An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer

NCT01964144 ·Status: COMPLETED ·Phase: PHASE2

CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT

NCT01760811 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer

NCT00768664 ·Status: COMPLETED ·Phase: PHASE2

GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma

NCT06827886 ·Status: COMPLETED ·Phase: EARLY_PHASE1

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

NCT05108870 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma

NCT06016920 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer

NCT01312324 ·Status: COMPLETED ·Phase: PHASE2

Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer

NCT02079324 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial Evaluating TG4050 in Head and Neck Cancer

NCT04183166 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2